About Us

MD MPH MBA Director Of Hematology and Oncology & Palliative Medicine I am a cancer doctor who treats patients with all types of cancer and blood disorders but have a special interest in complex gastrointestinal cancer. Treatment of these cancers can be challenging and have an impact on both the patient and their family. At House we understand that providing comprehensive care to patients and families struggling with these complex cancers requires a personalized and holistic approach. We are therefore committed to delivering whole-person care that provides hope, integrates personalized medicine, and offers access to innovative treatments through clinical trials, all while remembering the importance of a person’s quality of life. These are guiding principles for our cancer team at House Medicine. Dr. Shinde is the Director of Hematology and Oncology at House Medicine. He earned his Bachelor of Science in neuroscience, with honors, from UCLA and went on to earn his medical degree from the University of Southern California. While he was in medical school, his interest in understanding the economics behind healthcare and strategies for addressing health disparities led to his completion of a Master of Business Administration from University of Southern California and a Master in Public Health from Harvard University, with a focus on health administration and policy. Afterward, he completed a residency in Internal Medicine at Cedars-Sinai Medical Center. Dr. Shinde went on to complete a fellowship in Hospice and Palliative Medicine at San Diego Hospice and the Institute for Palliative Medicine, and a fellowship in Hematology and Oncology at City of Hope/Harbor-UCLA Medical Center. He is an Assistant Professor of Medicine at the UCLA Geffen School of Medicine, and provides clinical care with privileges at multiple hospitals in Los Angeles. Dr. Shinde’s clinical focus is twofold: along with colleagues in surgery, gastroenterology, radiation oncology and radiology, he participates in a multidisciplinary team to provide oncologic care to patients with gastrointestinal malignancies; he also provides supportive and palliative care services to patients and families receiving care for complex and advanced illnesses, including those undergoing curative therapies. Dr. Shinde’s current research interests include evaluating novel therapies for the treatment of liver, bile duct, and pancreatic cancers, identifying novel therapeutic targets through tissue genomics/proteomics, improving patient quality of life through optimization of supportive care, and utilizing wearable and other novel technologies to improve patient outcomes. He has presented his research on all of these topics at international symposia and published in peer review journals.